XML 59 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Incentive Plans and Warrants (Tables)
12 Months Ended
Dec. 31, 2012
Equity Incentive Plans and Warrants [Abstract]  
Share-based compensation expense by category
                         
    Years Ended December 31,  
    2012     2011     2010  

Continuing Operations:

                       

Cost of product and contract manufacturing revenue

  $ 76     $ 0     $ 0  

Research and development

    191       280       0  

Selling, general and administrative

    801       484       1,091  

Restructuring charges

    0       583       0  
   

 

 

   

 

 

   

 

 

 
    $ 1,068     $ 1,347     $ 1,091  
   

 

 

   

 

 

   

 

 

 

Discontinued Operations:

                       

Research and development

  $ 0     $ 0     $ 16  

Selling, general and administrative

    0       90       213  
   

 

 

   

 

 

   

 

 

 
    $ 0     $ 90     $ 229  
   

 

 

   

 

 

   

 

 

 
    $ 1,068     $ 1,437     $ 1,320  
   

 

 

   

 

 

   

 

 

 
Fair value of stock options awards
             
   

December 31,

   

2012

 

2011

 

2010

Risk-free interest rate

  0.97% to 1.67%   1.4% to 3.0%   1.9% to 3.2%

Dividend Yield

  0%   0%   0%

Volatility

  66.91%   66.91% to 135%   135%

Expected Life

  6 years   6 years   6 years
Share-based compensation expense outstanding unvested options to be recognized
         

Fiscal Year 2013

  $
1,013
 

Fiscal Year 2014

    512  

Fiscal Year 2015

    216  

Fiscal Year 2016

    61  

Thereafter

    22  
   

 

 

 
    $ 1,824  
   

 

 

 
Summary of Company's stock option activity
                                 
    Shares     Weighted
Average Exercise
Price per Share
    Weighted
Average Remaining
Contractual Term

(in Years)
    Aggregate
Intrinsic Value
 

Outstanding at January 1, 2010

    787     $ 15.75                  

Granted

    784     $ 2.90                  

Exercised

    (11   $ 1.37                  

Cancelled

    (351   $ 22.62                  
   

 

 

   

 

 

                 

Outstanding at December 31, 2010

    1,209     $ 5.56                  

Granted

    884     $ 2.20                  

Exercised

    (2   $ 0.72                  

Cancelled

    (272   $ 11.30                  
   

 

 

   

 

 

                 

Outstanding at December 31, 2011

    1,819     $ 3.07                  

Granted

    551     $ 4.08                  

Exercised

    (174   $ 2.86                  

Cancelled

    (203   $ 3.12                  
   

 

 

   

 

 

                 

Outstanding at December 31, 2012

    1,993     $ 3.36       8.4     $ 257  
   

 

 

   

 

 

                 

Exercisable at December 31, 2012

    715     $ 3.76       7.7     $ 81  
   

 

 

   

 

 

                 
Company's non-restricted and restricted share awards
                 
    Shares     Weighted
Average
Fair  Value
 

Non-vested awards outstanding at January 1, 2010

    8     $ 15.62  

Granted

    10     $ 3.05  

Vested

    (6   $ 14.51  

Forfeited and cancelled

    (2   $ 14.64  
   

 

 

   

 

 

 

Non-vested awards outstanding at December 31, 2010

    10     $ 3.67  

Granted

    0     $ 0.00  

Vested

    (6   $ 3.87  

Forfeited and cancelled

    0     $ 0.00  
   

 

 

   

 

 

 

Non-vested awards outstanding at December 31, 2011

    4     $ 3.35  

Granted

    0     $ 0.00  

Vested

    (4   $ 3.05  

Forfeited and cancelled

    0     $ 0.00  
   

 

 

   

 

 

 

Non-vested awards outstanding at December 31, 2012

    0     $ 0  
   

 

 

   

 

 

 
Summary of outstanding warrants
                         

Warrant Holder

  Shares     Exercise Price    

Issue Date

 

Expiration Date

Athyrium Opportunities Fund

    2,936     $ 2.49     December 2012   December 2019

Comerica Bank

    246     $ 2.64     October 2011   October 2016

Various (Public offering)

    900     $ 7.59     October 2009   October 2014

Various (Celunol)

    28     $ 22.44     various   December 2016

Various (2008 Notes)

    1,193     $ 29.72     February 2008   August 2013

Convertible hedge–Upper Call (2008 Notes)

    1,107     $ 61.92     February 2008   October 2014

Syngenta

    108     $ 208.73     February 2003   February 2018
   

 

 

                 

Total

    6,518                  
   

 

 

                 
Company has reserved shares of common stock for future issuance
         
    Shares  

Equity Incentive Plans

    2,636  

Warrants (including shares issuable under the convertible hedge transaction)

    6,518  
   

 

 

 
      9,154